Development of GPC-3/EGFR, GPC-3/ASGR1, and αFP /MHC complex CAR-T cells has been associated with improved activation, expansion, and persistence of the T cells, as well as stronger cytotoxicity in double-positive tumor cell groups [41,42,43]. The gene discussed is GPC3; the disease is neoplasm.